Literature DB >> 25212721

In vivo predictive dissolution: transport analysis of the CO2 , bicarbonate in vivo buffer system.

Brian J Krieg1, Seyed Mohammad Taghavi2, Gordon L Amidon3, Gregory E Amidon1.   

Abstract

Development of an oral in vivo predictive dissolution medium for acid drugs with a pKa in the physiological range (e.g., Biopharmaceutics Classification System Class IIa) requires transport analysis of the complex in vivo CO2 /bicarbonate buffering system. In this report, we analyze this buffer system using hydrodynamically defined rotating disk dissolution. Transport analysis of drug flux was predicted using the film model approach of Mooney et al based on equilibrium assumptions as well as accounting for the slow hydration reaction, CO2 + H2 O → H2 CO3 . The accuracy of the models was compared with experimentally determined results using the rotating disk dissolution of ibuprofen, indomethacin, and ketoprofen. The equilibrium and slow hydration reaction rate models predict significantly different dissolution rates. The experimental results are more accurately predicted by accounting for the slow hydration reaction under a variety of pH and hydrodynamic conditions. Although the complex bicarbonate buffering system requires further consideration given its dynamic nature in vivo, a simplifying irreversible reaction (IRR) transport analysis accurately predicts in vitro rotating disk dissolution rates of several carboxylic acid drugs. This IRR transport model provides further insight into bicarbonate buffer and can be useful in developing more physiologically relevant buffer systems for dissolution testing.
© 2014 Wiley Periodicals, Inc. and the American Pharmacists Association.

Entities:  

Keywords:  acid-base equilibria; diffusion; dissolution; in vitro models; mathematical model; physicochemical; transport

Mesh:

Substances:

Year:  2014        PMID: 25212721     DOI: 10.1002/jps.24108

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  14 in total

Review 1.  A Critical Overview of the Biological Effects of Excipients (Part II): Scientific Considerations and Tools for Oral Product Development.

Authors:  Marilyn N Martinez; Fang Wu; Balint Sinko; David J Brayden; Michael Grass; Filippos Kesisoglou; Aaron Stewart; Kiyohiko Sugano
Journal:  AAPS J       Date:  2022-05-02       Impact factor: 4.009

2.  Understanding In Vivo Dissolution of Immediate Release (IR) Solid Oral Drug Products Containing Weak Acid BCS Class 2 (BCS Class 2a) Drugs.

Authors:  Min Li; Xinwen Zhang; Di Wu; Om Anand; Hansong Chen; Kimberly Raines; Lawrence Yu
Journal:  AAPS J       Date:  2021-10-26       Impact factor: 4.009

3.  Physiologically Based Biopharmaceutics Model for Selumetinib Food Effect Investigation and Capsule Dissolution Safe Space - Part I: Adults.

Authors:  Xavier J H Pepin; Maria Hammarberg; Alexandra Mattinson; Andrea Moir
Journal:  Pharm Res       Date:  2022-08-24       Impact factor: 4.580

4.  Measuring the Impact of Gastrointestinal Variables on the Systemic Outcome of Two Suspensions of Posaconazole by a PBPK Model.

Authors:  Bart Hens; Arjang Talattof; Paulo Paixão; Marival Bermejo; Yasuhiro Tsume; Raimar Löbenberg; Gordon L Amidon
Journal:  AAPS J       Date:  2018-03-29       Impact factor: 4.009

Review 5.  Formulation predictive dissolution (fPD) testing to advance oral drug product development: An introduction to the US FDA funded '21st Century BA/BE' project.

Authors:  Bart Hens; Patrick D Sinko; Nicholas Job; Meagan Dean; Jozef Al-Gousous; Niloufar Salehi; Robert M Ziff; Yasuhiro Tsume; Marival Bermejo; Paulo Paixão; James G Brasseur; Alex Yu; Arjang Talattof; Gail Benninghoff; Peter Langguth; Hans Lennernäs; William L Hasler; Luca Marciani; Joseph Dickens; Kerby Shedden; Duxin Sun; Gregory E Amidon; Gordon L Amidon
Journal:  Int J Pharm       Date:  2018-06-23       Impact factor: 5.875

6.  Linking the Gastrointestinal Behavior of Ibuprofen with the Systemic Exposure between and within Humans-Part 2: Fed State.

Authors:  Paulo Paixão; Marival Bermejo; Bart Hens; Yasuhiro Tsume; Joseph Dickens; Kerby Shedden; Niloufar Salehi; Mark J Koenigsknecht; Jason R Baker; William L Hasler; Robert Lionberger; Jianghong Fan; Jeffrey Wysocki; Bo Wen; Allen Lee; Ann Frances; Gregory E Amidon; Alex Yu; Gail Benninghoff; Raimar Löbenberg; Arjang Talattof; Duxin Sun; Gordon L Amidon
Journal:  Mol Pharm       Date:  2018-11-12       Impact factor: 4.939

7.  In Vivo Predictive Dissolution and Simulation Workshop Report: Facilitating the Development of Oral Drug Formulation and the Prediction of Oral Bioperformance.

Authors:  Yasuhiro Tsume; Sanjaykumar Patel; Nikoletta Fotaki; Christel Bergstrӧm; Gordon L Amidon; James G Brasseur; Deanna M Mudie; Duxin Sun; Marival Bermejo; Ping Gao; Wei Zhu; David C Sperry; Maria Vertzoni; Neil Parrott; Robert Lionberger; Atsushi Kambayashi; Andre Hermans; Xujin Lu; Gregory E Amidon
Journal:  AAPS J       Date:  2018-09-06       Impact factor: 4.009

8.  Capture and displacement-based release of the bicarbonate anion by calix[4]pyrroles with small rigid straps.

Authors:  Nam Jung Heo; Ju Ho Yang; Vincent M Lynch; Byoung Joon Ko; Jonathan L Sessler; Sung Kuk Kim
Journal:  Chem Sci       Date:  2020-07-24       Impact factor: 9.825

9.  A Mechanistic Physiologically-Based Biopharmaceutics Modeling (PBBM) Approach to Assess the In Vivo Performance of an Orally Administered Drug Product: From IVIVC to IVIVP.

Authors:  Marival Bermejo; Bart Hens; Joseph Dickens; Deanna Mudie; Paulo Paixão; Yasuhiro Tsume; Kerby Shedden; Gordon L Amidon
Journal:  Pharmaceutics       Date:  2020-01-17       Impact factor: 6.321

10.  Linking the Gastrointestinal Behavior of Ibuprofen with the Systemic Exposure between and within Humans-Part 1: Fasted State Conditions.

Authors:  Marival Bermejo; Paulo Paixão; Bart Hens; Yasuhiro Tsume; Mark J Koenigsknecht; Jason R Baker; William L Hasler; Robert Lionberger; Jianghong Fan; Joseph Dickens; Kerby Shedden; Bo Wen; Jeffrey Wysocki; Raimar Löbenberg; Allen Lee; Ann Frances; Gregory E Amidon; Alex Yu; Niloufar Salehi; Arjang Talattof; Gail Benninghoff; Duxin Sun; Gislaine Kuminek; Katie L Cavanagh; Naír Rodríguez-Hornedo; Gordon L Amidon
Journal:  Mol Pharm       Date:  2018-11-12       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.